Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

46.00
+0.57001.25%
Post-market: 46.000.00000.00%16:42 EDT
Volume:657.58K
Turnover:30.20M
Market Cap:2.58B
PE:40.21
High:46.10
Open:45.39
Low:45.19
Close:45.43
52wk High:46.10
52wk Low:29.16
Shares:56.07M
Float Shares:48.90M
Volume Ratio:1.11
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.14
EPS(LYR):1.34
ROE:6.38%
ROA:2.39%
PB:2.42
PE(LYR):34.31

Loading ...

Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities